Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control

Related Experiment Video

Updated: Aug 20, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

C L Harper-Wynne, K Sumpter, C Ryan

    Lung Cancer (Amsterdam, Netherlands)
    |January 11, 2005
    PubMed
    Abstract

    No abstract available in PubMed .

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...